The Fight Against Prostate Cancer: What Men Need to Know
December 08, 2016 09:00 ET
|
Bio-Reference Laboratories, Inc.
NEW YORK, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Prostate cancer is the second most common cancer among men, and it is estimated that nearly three million men are living with the disease in the United...
Bio-Reference Laboratories, Inc. Reports Solid Revenues and Earnings for Q2FY15
June 08, 2015 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., June 8, 2015 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announces its second quarter results. Except for per share data in quotations or where otherwise...
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2015
June 01, 2015 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., June 1, 2015 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for second quarter 2015 before the open of market...
BioReference Laboratories se asocia con organizaciones para acelerar la innovación médica
April 14, 2015 17:48 ET
|
Bio-Reference Laboratories, Inc.
-- Lanzamiento del primer servicio Beacon de la Alianza Global para la Genómica y la Salud, desarrollado por un laboratorio comercial.
-- Presentación en la conferencia de primavera...
BioReference Laboratories faz parceria com organizações que aceleram inovações médicas
April 14, 2015 17:48 ET
|
Bio-Reference Laboratories, Inc.
-- Lança o primeiro beacon da Global Alliance for Genomics and Health feita por um laboratório comercial
-- Apresentada na Pistoia Alliance Spring Conference 2015 realizada em...
BioReference Laboratories Partners With Organizations Accelerating Medical Innovation
April 14, 2015 00:01 ET
|
Bio-Reference Laboratories, Inc.
Launches first Global Alliance for Genomics and Health Beacon by a commercial laboratory
Presenting at Pistoia Alliance Spring Conference 2015 being held in Zurich, Switzerland
ELMWOOD PARK,...
Bio-Reference Laboratories, Inc. Reports Over 15% Increase in Revenue; Net Income Up Over 100%, Year Over Year
March 05, 2015 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., March 5, 2015 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announces first quarter results. Except for per share data or where otherwise noted, numbers are in...
BioReference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2015
February 26, 2015 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Feb. 26, 2015 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for first quarter 2015 before the open of market...
BioReference Laboratories, Inc. Launches OnkoSight(TM), an Advanced Tumor Sequencing Program
February 25, 2015 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announced today the introduction of two new sequencing tests that the Company believes will...
BioReference Laboratories, Inc. Hires Industry Veteran, Joseph F. Donahue, to Lead New Business Group
February 12, 2015 08:30 ET
|
Bio-Reference Laboratories, Inc.
ELMWOOD PARK, N.J., Feb. 12, 2015 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today the formation of a new business group — the Commercial Collaborations and...